Inactive Instrument

NeuroOne Medical Technologies Corporation Stock Other OTC

Equities

NMTC

US64130M1009

Advanced Medical Equipment & Technology

Sales 2022 2.12 Sales 2023 3.41 Capitalization 21.3M
Net income 2022 -10M Net income 2023 -11M EV / Sales 2022 7,761,717 x
Net cash position 2022 10.94M Net cash position 2023 5.14M EV / Sales 2023 4,742,168 x
P/E ratio 2022
-2.7 x
P/E ratio 2023
-1.36 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 87.8%
More Fundamentals * Assessed data
Dynamic Chart
NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System CI
Transcript : NeuroOne Medical Technologies Corporation, Q1 2024 Earnings Call, Feb 13, 2024
NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Transcript : NeuroOne Medical Technologies Corporation, Q4 2023 Earnings Call, Dec 14, 2023
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Full Year Ended September 30, 2023 CI
NeuroOne Gets FDA Clearance to Market OneRF Ablation System; Shares Fall MT
NeuroOne Medical Technologies Corporation Receives FDA 510(K) Clearance to Market its OneRF(TM) Ablation System CI
NeuroOne Medical Technologies Gets Notice of Allowance for Drug Delivery Patent MT
NeuroOne Medical Technologies Corporation Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe CI
NeuroOne Medical Technologies Names Christopher Volker as Chief Operating Officer MT
NeuroOne Medical Technologies Corporation Appoints Christopher R. Volker as Chief Operating Officer CI
NeuroOne Medical Technologies Corporation Provides Progress Update on FDA 510(k) Submission for OneRF?? Ablation System CI
Alliance Global Partners Trims Price Target on NeuroOne Medical Technologies to $2.20 From $3.25, Maintains Buy Rating MT
Transcript : NeuroOne Medical Technologies Corporation, Q3 2023 Earnings Call, Aug 14, 2023
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
More news

Latest transcript on NeuroOne Medical Technologies Corporation

Managers TitleAgeSince
Founder 56 09-08-19
Chief Executive Officer 59 17-07-19
Director of Finance/CFO 65 20-12-31
Members of the board TitleAgeSince
Chairman 68 17-08-03
Director/Board Member 63 17-08-03
Director/Board Member 66 20-02-17
More insiders
NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.
More about the company